NCT02447263View on ClinicalTrials.gov

HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA） for Liver Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

87

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions
Liver Cancer
Interventions
PROCEDURE

interventional therapy

liver cancer patients received HepaSphere interventional therapy using the digital subtraction angiography（DSA）

Trial Locations (1)

510000

Central laboratory in Fuda cancer hospital, Guangzhou

All Listed Sponsors
lead

Fuda Cancer Hospital, Guangzhou

OTHER

NCT02447263 - HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA） for Liver Cancer | Biotech Hunter | Biotech Hunter